wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33405714-028A80F6-57F1-468F-8514-81A27B6342EF
Q33405714-028A80F6-57F1-468F-8514-81A27B6342EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405714-028A80F6-57F1-468F-8514-81A27B6342EF
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.
P2860
Q33405714-028A80F6-57F1-468F-8514-81A27B6342EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33405714-028A80F6-57F1-468F-8514-81A27B6342EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1eab6a3914a2b2ff6fc37b1c3d153c36fd7fe591
P2860
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.